RMD Oct 2024 195.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 09:30AM EDT. Market open.
| Previous close | 50.45 |
| Open | 50.45 |
| Bid | 37.40 |
| Ask | 41.50 |
| Strike | 195.00 |
| Expiry date | 2024-10-18 |
| Day's range | 50.45 - 50.45 |
| Contract range | N/A |
| Volume | |
| Open interest | 172 |
GlobeNewswireResMed to Report First Quarter Fiscal 2025 Earnings on October 24, 2024
SAN DIEGO, Oct. 03, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2025 on Thursday, October 24, 2024, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details: Location: http://investor.resmed.com Date
ZacksZacks.com featured highlights Ferrari, Vertex, ResMed and Hubbel
Ferrari, Vertex, ResMed and Hubbel have been highlighted in this Screen of The Week article.
Barrons.comResMed Stock Is Surging. Expect More Gains for the Medical Equipment Maker.
Fears that GLP-1 obesity drugs would reduce demand for ResMed’s various CPAP airflow machines have proven unfounded..
© 2024 Yahoo. All rights reserved.